| 000 | 01518 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517015440.0 | ||
| 264 | 0 | _c20160628 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.2909 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHyman, David M | |
| 245 | 0 | 0 |
_aPredictors of early treatment discontinuation in patients enrolled on Phase I oncology trials. _h[electronic resource] |
| 260 |
_bOncotarget _cAug 2015 |
||
| 300 |
_a19316-27 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xmethods |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEaton, Anne A | |
| 700 | 1 | _aGounder, Mrinal M | |
| 700 | 1 | _aPamer, Erika G | |
| 700 | 1 | _aPettiford, Jasmine | |
| 700 | 1 | _aCarvajal, Richard D | |
| 700 | 1 | _aIvy, S Percy | |
| 700 | 1 | _aIasonos, Alexia | |
| 700 | 1 | _aSpriggs, David R | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 22 _gp. 19316-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.2909 _zAvailable from publisher's website |
| 999 |
_c24624550 _d24624550 |
||